SPECIALTY / DIRECT CATALOG PRICING
HMG
Human menopausal gonadotropin (hMG), or menotropins, is a biologically standardized mixture with follicle-stimulating-hormone and luteinizing-hormone activity, historically isolated from postmenopausal urine.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Specialty
Choose a listed format
- 75 IURequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Human menopausal gonadotropin (hMG), or menotropins, is a biologically standardized mixture with follicle-stimulating-hormone and luteinizing-hormone activity, historically isolated from postmenopausal urine.
The specialty classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Specialty
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Human menopausal gonadotropin (hMG), or menotropins, is a biologically standardized mixture with follicle-stimulating-hormone and luteinizing-hormone activity, historically isolated from postmenopausal urine.
- Research covered
- FDA Menopur and Repronex records describe licensed, manufacturer-specific menotropins preparations and their biological standardization. Those sources establish what an approved menotropins product is, not the identity of this catalog vial.
- Important limit
- The catalog's 75 IU entry does not identify FSH:LH activity, source, assay, manufacturer, or excipients. 'HMG' alone is insufficient to show equivalence to an FDA-reviewed product.
FACTUAL FAQ
HMG catalog questions
What formats are currently listed?
75 IU. Current price and stock state appear above.
What did researchers study?
FDA Menopur and Repronex records describe licensed, manufacturer-specific menotropins preparations and their biological standardization. Those sources establish what an approved menotropins product is, not the identity of this catalog vial.
What is the most important evidence limit?
The catalog's 75 IU entry does not identify FSH:LH activity, source, assay, manufacturer, or excipients. 'HMG' alone is insufficient to show equivalence to an FDA-reviewed product.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →